Te
Terray Ther
Pasadena CAFounded 202160 employees
Private CapbiotechPrivateOncology
Platform: Nanotechnology
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TER-8481 | TER-8481 | Phase 1/2 | 2 | KRASG12C | GBMUrothelial Ca | ||
| TER-2947 | TER-2947 | Phase 3 | 2 | CFTR | Urothelial Ca | ||
| TER-1034 | TER-1034 | Phase 3 | 2 | FGFR | Melanoma | ||
| Doxazanubrutinib | TER-9641 | Phase 3 | 1 | PARP | SchizophreniaGA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)